Financing type: brokered private placement
Gross proceeds: $4,001,250 (U.S.)
Offering: 970,000 common shares with 970,000 warrants attached
Offering price: $4.125 (U.S.) per common share
Warrant exercise terms: $4.64 (U.S.) per common share for a five-year period
Overallotment option: The company has granted the underwriters a 45-day option to purchase up to 145,500 common shares and/or warrants at the initial public offering price to cover overallotments, if any.
Disclosure: Refer to the company's news releases dated May 29, 2024, Oct. 28, 2024, Nov. 13, 2024, and Nov. 15, 2024.
© 2025 Canjex Publishing Ltd. All rights reserved.